p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation

[1]  Tony Zigmond.  Mental health law across the UK† , 2017, BJPsych Bulletin.

[2]  G. Bloomfield,et al.  Features of cardiovascular disease in low-income and middle-income countries in adults and children living with HIV , 2017, Current opinion in HIV and AIDS.

[3]  J. Potter,et al.  Women Living with HIV over Age of 65: Cervical Cancer Screening in a Unique and Growing Population , 2017, Infectious diseases in obstetrics and gynecology.

[4]  M. Salmona,et al.  HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders , 2017, Scientific Reports.

[5]  L. Milanesi,et al.  A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17 , 2017, Scientific Reports.

[6]  T. Burdo,et al.  HIV-1-Associated Atherosclerosis: Unraveling the Missing Link. , 2017, Journal of the American College of Cardiology.

[7]  C. Giagulli,et al.  Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis , 2017, Journal of Virology.

[8]  Z. Mbita,et al.  Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers , 2017, HIV/AIDS.

[9]  A. Carbone,et al.  The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis , 2017, International journal of cancer.

[10]  Y. Lan,et al.  Association of HIV and Opportunistic Infections With Incident Stroke: A Nationwide Population-Based Cohort Study in Taiwan , 2017, Journal of acquired immune deficiency syndromes.

[11]  Jessica L. Montoya,et al.  Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy , 2017, Journal of acquired immune deficiency syndromes.

[12]  N. Seecheran,et al.  Acute coronary syndromes in patients with HIV , 2016, Coronary artery disease.

[13]  M. Lederman,et al.  Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to Vascular Inflammation in Human Immunodeficiency Virus Infection , 2016, Open forum infectious diseases.

[14]  J. Bruce.  The difficulties of ‘living while girl’ , 2016, Journal of virus eradication.

[15]  Guixue Wang,et al.  High shear stress induces atherosclerotic vulnerable plaque formation through angiogenesis , 2016, Regenerative biomaterials.

[16]  C. Longenecker,et al.  Acute Spontaneous Coronary Artery Thrombosis as Initial Presentation of HIV Infection in a Young Man , 2015, Case reports in cardiology.

[17]  Xianglin L. Du,et al.  Cumulative HIV Viremia and Non–AIDS-Defining Malignancies Among a Sample of HIV-Infected Male Veterans , 2014, Journal of acquired immune deficiency syndromes.

[18]  M. Capobianchi,et al.  Detection of HIV-1 Matrix Protein p17 Quasispecies Variants in Plasma of Chronic HIV-1–Infected Patients by Ultra-Deep Pyrosequencing , 2014, Journal of acquired immune deficiency syndromes.

[19]  B. Brew,et al.  Update on HIV Dementia and HIV-Associated Neurocognitive Disorders , 2014, Current Neurology and Neuroscience Reports.

[20]  M. Slevin,et al.  HIV-1 Matrix Protein p17 Promotes Lymphangiogenesis and Activates the Endothelin-1/Endothelin B Receptor Axis , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Sandeep Grover,et al.  Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease , 2014, BMC Genomics.

[22]  I. Barone,et al.  Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 1 Matrix Proteins Specify Different Capabilities To Modulate B Cell Growth , 2014, Journal of Virology.

[23]  N. Robinson,et al.  Complementary therapy provision in a London community clinic for people living with HIV/AIDS: a case study. , 2014, Complementary therapies in clinical practice.

[24]  M. Imoto,et al.  5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation , 2014, Cancer science.

[25]  P. Hartge,et al.  The Epidemic of Non–Hodgkin Lymphoma in the United States: Disentangling the Effect of HIV, 1992–2009 , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[26]  L. Pulliam,et al.  Monocyte Activation in HIV/HCV Coinfection Correlates with Cognitive Impairment , 2013, PloS one.

[27]  D. Ribatti,et al.  HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 , 2012, Proceedings of the National Academy of Sciences.

[28]  D. Francisci,et al.  The HIV Matrix Protein p17 Subverts Nuclear Receptors Expression and Induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes , 2012, PloS one.

[29]  A. Magiera,et al.  HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation. , 2012, Blood.

[30]  I. Barone,et al.  Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells , 2011, PloS one.

[31]  A. Magiera,et al.  HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS. , 2010, Pharmacology & therapeutics.

[32]  O. Martínez-Maza,et al.  HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma , 2010, Immunologic research.

[33]  A. Mocroft,et al.  Incidence and Risk Factors of HIV-Related Non-Hodgkin's Lymphoma in the era of Combination Antiretroviral Therapy: A European Multicohort Study , 2009, Antiviral therapy.

[34]  E. Masliah,et al.  Molecular Pathology of Neuro-AIDS (CNS-HIV) , 2009, International journal of molecular sciences.

[35]  S. Sozzani,et al.  HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype , 2008, Proceedings of the National Academy of Sciences.

[36]  A. Justice,et al.  Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  C. Guzmán,et al.  HIV‐1 matrix protein p17 binds to monocytes and selectively stimulates MCP‐1 secretion: role of transcriptional factor AP‐1 , 2007, Cellular microbiology.

[38]  Maria Flora Salvatori,et al.  Persistence of Neuropsychologic Deficits Despite Long-TermHighlyActiveAntiretroviralTherapyinPatients With HIV-Related Neurocognitive Impairment: Prevalence and Risk Factors , 2007, Journal of acquired immune deficiency syndromes.

[39]  R. Miller,et al.  HIV infection and lymphoma , 2006, Journal of Clinical Pathology.

[40]  J. Justman,et al.  Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women , 2006, AIDS.

[41]  Mikulas Popovic,et al.  Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Narciso,et al.  Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. , 2005, AIDS research and human retroviruses.

[43]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.

[44]  I. Nishimoto,et al.  The Cytoplasmic Domain of Alzheimer's Amyloid-β Protein Precursor Causes Sustained Apoptosis Signal-Regulating Kinase 1/c-Jun NH2-Terminal Kinase-Mediated Neurotoxic Signal via Dimerization , 2003, Journal of Pharmacology and Experimental Therapeutics.

[45]  M. Skobe,et al.  Lymphangiogenesis and tumor metastasis , 2003, Cell and Tissue Research.

[46]  L. Rodella,et al.  HIV‐1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines , 2003, British journal of haematology.

[47]  R. Gallo,et al.  HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  E. Chiao,et al.  Malignancies in women with HIV infection , 2017, Current opinion in HIV and AIDS.

[49]  P. Grammas,et al.  A new paradigm for the treatment of Alzheimer's disease: targeting vascular activation. , 2014, Journal of Alzheimer's disease : JAD.

[50]  K. Marder,et al.  An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. , 2007, Archives of neurology.

[51]  S. Fiorentini,et al.  Functions of the HIV-1 matrix protein p17. , 2006, The new microbiologica.